Futura Medical downgrades FY revenue guidance
19th Sep 2025 13:01
(Sharecast News) - Futura Medical warned on Friday that full-year revenue was set to be "materially below expectations" following a review of forecast revenue streams.
Read moreFutura appoints interim CEO as erection gel disappoints
8th Aug 2025 12:55
(Sharecast News) - Futura Medical announced the appointment of Alex Duggan as its interim chief executive officer on Friday, following the completion of all regulatory and due diligence requirements.
Read moreFutura Medical reports progress with R&D pipeline
4th Nov 2024 14:21
(Sharecast News) - Futura Medical announced encouraging progress in its product development pipeline on Monday, with successful proof-of-concept results for two new treatments addressing sexual dysfunction.
Read moreFutura Medical due $5m milestone payment from Haleon
7th Oct 2024 14:17
(Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
Read moreFutura has 'transformational year' in 2023
6th Feb 2024 10:08
(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".
Read moreFutura Medical extends agreement with Cooper Consumer Health
15th Jan 2024 14:59
(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.
Read moreFutura Medical wis European patent for erectile dysfunction gel
2nd Oct 2023 14:22
(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.
Read moreFutura Medical shares rise on ED licensing deal with Haleon
17th Jul 2023 08:33
(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.
Read moreFutura's erection gel launched over-the-counter in the UK
18th Apr 2023 13:09
(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.
Read moreFutura gearing up for US approval, launches of erection gel
13th Dec 2022 12:51
(Sharecast News) - Drug delivery technology developer Futura Medical updated the market on the regulatory progress and recent commercial activities for its 'MED3000' topical gel treatment for erectile dysfunction (ED).
Read moreFutura Medical completes FDA work for erectile treatment
3rd Oct 2022 13:13
(Sharecast News) - Futura Medical has completed the work required for the FDA to grant marketing authorisation for 'MED3000', its fast acting clinically proven treatment for erectile dysfunction, it announced on Monday.
Read moreFutura signs up Korean partner for erection gel product
23rd Mar 2022 15:35
(Sharecast News) - Pharmaceutical and drug delivery technology developer Futura Medical has entered into a licensing agreement with Menarini Korea, it announced on Wednesday, for the exclusive rights to commercialise the company's topical gel-based erectile dysfunction treatment MED3000 in South Korea.
Read moreFutura Medical makes good progress with topical erection gel treatment
20th Dec 2021 10:46
(Sharecast News) - Futura Medical updated the market on regulatory and commercial progress for 'MED3000', its topical gel formulation for the treatment of erectile dysfunction, on Monday.
Read moreFutura Medical inks licensing deal with Labtec Pharma
27th Sep 2021 16:54
(Sharecast News) - Transdermal drug delivery technology company Futura Medical has entered into a licensing agreement with Labatec Pharma, a Switzerland-based specialty pharma company focussed on commercialisation in the Europe and Middle East and North Africa (MENA) regions, it announced on Monday.
Read moreFutura enters erection gel licensing deal with M8
31st Aug 2021 15:08
(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.
Read more